Ratings changes for Microsoft, Cassava Sciences, JD.com, Affirm, QUALCOMM, SolarEdge Technologies, Micron Technology and more…Text “MarketBeat” to  68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports.  Learn More.
A strange force has seized control of Wall Street. Hedge funds are already moving their money… and preparing for even stranger days ahead. Over 320 hedge funds have quietly sold THIS famous stock – to prepare for a dramatic market shift
Microsoft (NASDAQ:MSFT) was downgraded by analysts at Oppenheimer Holdings Inc. (Â Â Â Â ) from an “outperform” rating to a “market perform” rating.The current price is $413.35.
Affirm (NASDAQ:AFRM) was upgraded by analysts at BTIG Research from a “neutral” rating to a “buy” rating. They now have a $68.00 price target on the stock. This represents a 68.5% upside from the current price of $40.36.
CEMEX (NYSE:CX) was upgraded by analysts at Royal Bank of Canada from an “underperform” rating to a “sector perform” rating. They now have a $6.50 price target on the stock, down previously from $9.00. This represents a 11.3% upside from the current price of $5.84.
Humana (NYSE:HUM) was upgraded by analysts at Sanford C. Bernstein from a “market perform” rating to an “outperform” rating. They now have a $308.00 price target on the stock. This represents a 26.5% upside from the current price of $243.43.
McDonald’s (NYSE:MCD) was upgraded by analysts at Argus from a “hold” rating to a “buy” rating.The current price is $301.08.
Cassava Sciences (NASDAQ:SAVA) was upgraded by analysts at HC Wainwright from a “neutral” rating to a “buy” rating. They now have a $116.00 price target on the stock. This represents a 291.4% upside from the current price of $29.64.
Sun Country Airlines (NASDAQ:SNCY) was upgraded by analysts at Wolfe Research from a “peer perform” rating to an “outperform” rating. They now have a $14.00 price target on the stock. This represents a 30.1% upside from the current price of $10.76.
Ubisoft Entertainment (OTCMKTS:UBSFY) was upgraded by analysts at UBS Group AG from a “sell” rating to a “neutral” rating.The current price is $2.95.
UFP Industries (NASDAQ:UFPI) was upgraded by analysts at Wedbush from a “neutral” rating to an “outperform” rating. They now have a $155.00 price target on the stock, up previously from $120.00. This represents a 16.6% upside from the current price of $132.94.
UWM (NYSE:UWMC) was upgraded by analysts at Barclays PLC from an “underweight” rating to an “equal weight” rating. They now have a $8.00 price target on the stock, up previously from $6.00. This represents a 9.0% upside from the current price of $7.34.
Waters (NYSE:WAT) was upgraded by analysts at Jefferies Financial Group Inc. from a “hold” rating to a “buy” rating. They now have a $415.00 price target on the stock, up previously from $355.00. This represents a 16.0% upside from the current price of $357.66.
Wells Fargo & Company (NYSE:WFC) was upgraded by analysts at Wolfe Research from a “peer perform” rating to an “outperform” rating. They now have a $65.00 price target on the stock. This represents a 13.0% upside from the current price of $57.54.
American Express (NYSE:AXP) was downgraded by analysts at BTIG Research from a “neutral” rating to a “sell” rating. They now have a $230.00 price target on the stock. This represents a 14.7% downside from the current price of $269.50.
American Express (NYSE:AXP) was downgraded by analysts at HSBC Holdings plc from a “buy” rating to a “hold” rating. They now have a $270.00 price target on the stock, up previously from $265.00. This represents a 0.2% upside from the current price of $269.50.
Anheuser-Busch InBev SA/NV (NYSE:BUD) was downgraded by analysts at TD Cowen from a “buy” rating to a “hold” rating. They now have a $88.00 price target on the stock, up previously from $68.00. This represents a 37.1% upside from the current price of $64.21.
CME Group (NASDAQ:CME) was downgraded by analysts at Redburn Atlantic from a “buy” rating to a “neutral” rating. They now have a $244.00 price target on the stock. This represents a 9.7% upside from the current price of $222.41.
Frontier Communications Parent (NASDAQ:FYBR) was downgraded by analysts at TD Cowen from a “buy” rating to a “hold” rating. They now have a $38.50 price target on the stock, down previously from $39.00. This represents a 8.8% upside from the current price of $35.39.
Microsoft (NASDAQ:MSFT) was downgraded by analysts at Oppenheimer Holdings Inc. from an “outperform” rating to a “market perform” rating.The current price is $412.97.
OneMain (NYSE:OMF) was downgraded by analysts at Barclays PLC from an “overweight” rating to an “equal weight” rating. They now have a $46.00 price target on the stock, down previously from $52.00. This represents a 0.3% upside from the current price of $45.88.
Otis Worldwide (NYSE:OTIS) was downgraded by analysts at Wolfe Research from an “outperform” rating to a “peer perform” rating.The current price is $101.09.
QUALCOMM (NASDAQ:QCOM) was downgraded by analysts at KeyCorp from an “overweight” rating to a “sector weight” rating.The current price is $166.04.
Constellation Brands (NYSE:STZ) was downgraded by analysts at TD Cowen from a “buy” rating to a “hold” rating. They now have a $270.00 price target on the stock, down previously from $300.00. This represents a 13.1% upside from the current price of $238.80.
Synaptics (NASDAQ:SYNA) was downgraded by analysts at KeyCorp from an “overweight” rating to a “sector weight” rating.The current price is $74.00.
Trip.com Group (NASDAQ:TCOM) was downgraded by analysts at HSBC Holdings plc from a “buy” rating to a “hold” rating.The current price is $62.97.
Abbott Laboratories (NYSE:ABT) is now covered by analysts at Oppenheimer Holdings Inc.. They set an “outperform” rating and a $130.00 price target on the stock. This represents a 13.9% upside from the current price of $114.18.
Arcellx (NASDAQ:ACLX) is now covered by analysts at Redburn Atlantic. They set a “buy” rating and a $109.00 price target on the stock. This represents a 40.6% upside from the current price of $77.50.
Bicara Therapeutics (NASDAQ:BCAX) is now covered by analysts at Cantor Fitzgerald. They set an “overweight” rating on the stock.The current price is $23.21.
Bicara Therapeutics (NASDAQ:BCAX) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $47.00 price target on the stock. This represents a 102.5% upside from the current price of $23.21.
Bicara Therapeutics (NASDAQ:BCAX) is now covered by analysts at TD Cowen. They set a “buy” rating on the stock.The current price is $23.21.
Bicara Therapeutics (NASDAQ:BCAX) is now covered by analysts at Morgan Stanley. They set an “overweight” rating and a $35.00 price target on the stock. This represents a 50.8% upside from the current price of $23.21.
Barclays (NYSE:BCS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating on the stock.The current price is $12.06.
Bitdeer Technologies Group (NASDAQ:BTDR) is now covered by analysts at Alliance Global Partners. They set a “buy” rating and a $14.00 price target on the stock. This represents a 96.1% upside from the current price of $7.14.
CION Investment (NYSE:CION) is now covered by analysts at Oppenheimer Holdings Inc.. They set a “market perform” rating and a $13.00 price target on the stock. This represents a 10.4% upside from the current price of $11.78.
CrowdStrike (NASDAQ:CRWD) is now covered by analysts at BNP Paribas. They set a “neutral” rating and a $285.00 price target on the stock. This represents a 1.3% downside from the current price of $288.89.
Curbline Properties (NYSE:CURB) is now covered by analysts at Citigroup Inc.. They set a “neutral” rating and a $25.00 price target on the stock. This represents a 5.6% upside from the current price of $23.68.
Datadog (NASDAQ:DDOG) is now covered by analysts at BNP Paribas. They set an “outperform” rating and a $150.00 price target on the stock. This represents a 20.2% upside from the current price of $124.79.
Dynatrace (NYSE:DT) is now covered by analysts at BNP Paribas. They set a “neutral” rating and a $52.00 price target on the stock. This represents a 2.5% downside from the current price of $53.33.
First National (NASDAQ:FXNC) is now covered by analysts at Hovde Group. They set an “outperform” rating and a $22.00 price target on the stock. This represents a 18.3% upside from the current price of $18.59.
Genmab A/S (NASDAQ:GMAB) is now covered by analysts at Redburn Atlantic. They set a “buy” rating on the stock.The current price is $23.59.
GRI Bio (NASDAQ:GRI) is now covered by analysts at Ascendiant Capital Markets. They set a “buy” rating and a $12.00 price target on the stock.
Howmet Aerospace (NYSE:HWM) is now covered by analysts at Susquehanna. They set a “positive” rating and a $120.00 price target on the stock. This represents a 16.1% upside from the current price of $103.35.
Samsara (NYSE:IOT) is now covered by analysts at BNP Paribas. They set a “neutral” rating and a $46.00 price target on the stock. This represents a 3.5% downside from the current price of $47.65.
Legend Biotech (NASDAQ:LEGN) is now covered by analysts at Redburn Atlantic. They set a “buy” rating and a $86.00 price target on the stock. This represents a 76.8% upside from the current price of $48.65.
Light & Wonder (NASDAQ:LNW) is now covered by analysts at B. Riley. They set a “buy” rating and a $120.00 price target on the stock. This represents a 24.9% upside from the current price of $96.08.
MBX Biosciences (NYSE:MBX) is now covered by analysts at JPMorgan Chase & Co.. They set an “overweight” rating and a $30.00 price target on the stock. This represents a 29.3% upside from the current price of $23.20.
MBX Biosciences (NYSE:MBX) is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating and a $35.00 price target on the stock. This represents a 50.9% upside from the current price of $23.20.
MBX Biosciences (NYSE:MBX) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $40.00 price target on the stock. This represents a 72.4% upside from the current price of $23.20.
MBX Biosciences (NYSE:MBX) is now covered by analysts at Guggenheim. They set a “buy” rating and a $44.00 price target on the stock. This represents a 89.7% upside from the current price of $23.20.
Morningstar (NASDAQ:MORN) is now covered by analysts at UBS Group AG. They set a “buy” rating and a $390.00 price target on the stock. This represents a 19.5% upside from the current price of $326.42.
Cloudflare (NYSE:NET) is now covered by analysts at BNP Paribas. They set an “underperform” rating and a $65.00 price target on the stock. This represents a 19.8% downside from the current price of $81.00.
Envista (NYSE:NVST) is now covered by analysts at Wells Fargo & Company. They set an “equal weight” rating and a $20.00 price target on the stock. This represents a 8.3% upside from the current price of $18.47.
Arcus Biosciences (NYSE:RCUS) is now covered by analysts at Wells Fargo & Company. They set an “overweight” rating and a $29.00 price target on the stock. This represents a 55.7% upside from the current price of $18.63.
Sable Offshore (NYSE:SOC) is now covered by analysts at BWS Financial. They set a “sell” rating and a $6.00 price target on the stock. This represents a 71.9% downside from the current price of $21.36.
Solventum (NYSE:SOLV) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $82.00 price target on the stock. This represents a 20.1% upside from the current price of $68.29.
Veeva Systems (NYSE:VEEV) is now covered by analysts at BNP Paribas. They set an “outperform” rating and a $286.00 price target on the stock. This represents a 39.7% upside from the current price of $204.74.
Zapp Electric Vehicles Group (NASDAQ:ZAPP) is now covered by analysts at Maxim Group. They set a “buy” rating and a $7.00 price target on the stock. This represents a 161.2% upside from the current price of $2.68.
ProShares UltraPro Short Nasdaq Biotechnology (NASDAQ:ZBIO) is now covered by analysts at Citigroup Inc.. They set a “buy” rating and a $27.00 price target on the stock. This represents a 44.4% upside from the current price of $18.70.
ProShares UltraPro Short Nasdaq Biotechnology (NASDAQ:ZBIO) is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating and a $35.00 price target on the stock. This represents a 87.2% upside from the current price of $18.70.
ProShares UltraPro Short Nasdaq Biotechnology (NASDAQ:ZBIO) is now covered by analysts at Morgan Stanley. They set an “overweight” rating and a $40.00 price target on the stock. This represents a 113.9% upside from the current price of $18.70.
ProShares UltraPro Short Nasdaq Biotechnology (NASDAQ:ZBIO) is now covered by analysts at Guggenheim. They set a “buy” rating and a $45.00 price target on the stock. This represents a 140.6% upside from the current price of $18.70.
Zscaler (NASDAQ:ZS) is now covered by analysts at BNP Paribas. They set a “neutral” rating and a $180.00 price target on the stock. This represents a 2.6% upside from the current price of $175.52.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checkbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
 
 
 Apple Inc. (AAPL)
 Amazon.com, Inc. (AMZN)
 Alphabet Inc. (GOOGL)
 Meta Platforms, Inc. (META)
 Microsoft Co. (MSFT)
 
 
